[go: up one dir, main page]

DE60125159D1 - Neue kombination von einem beta-blocker und einem cholesterin-senkenden mittel - Google Patents

Neue kombination von einem beta-blocker und einem cholesterin-senkenden mittel

Info

Publication number
DE60125159D1
DE60125159D1 DE60125159T DE60125159T DE60125159D1 DE 60125159 D1 DE60125159 D1 DE 60125159D1 DE 60125159 T DE60125159 T DE 60125159T DE 60125159 T DE60125159 T DE 60125159T DE 60125159 D1 DE60125159 D1 DE 60125159D1
Authority
DE
Germany
Prior art keywords
cholesterin
new combination
beta blocker
lowering medium
lowering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60125159T
Other languages
English (en)
Other versions
DE60125159T2 (de
Inventor
Goeran Bondjers
Olov Wiklund
John Wikstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001188A external-priority patent/SE0001188D0/xx
Priority claimed from SE0002352A external-priority patent/SE0002352D0/xx
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60125159D1 publication Critical patent/DE60125159D1/de
Application granted granted Critical
Publication of DE60125159T2 publication Critical patent/DE60125159T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60125159T 2000-04-03 2001-03-27 Neue kombination von einem beta-blocker und einem cholesterin-senkenden mittel Expired - Fee Related DE60125159T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0001188A SE0001188D0 (sv) 2000-04-03 2000-04-03 New combination
SE0001188 2000-04-03
SE0002352 2000-06-22
SE0002352A SE0002352D0 (sv) 2000-06-22 2000-06-22 New combination
PCT/SE2001/000663 WO2001074394A1 (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Publications (2)

Publication Number Publication Date
DE60125159D1 true DE60125159D1 (de) 2007-01-25
DE60125159T2 DE60125159T2 (de) 2007-10-25

Family

ID=26655059

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60125159T Expired - Fee Related DE60125159T2 (de) 2000-04-03 2001-03-27 Neue kombination von einem beta-blocker und einem cholesterin-senkenden mittel

Country Status (24)

Country Link
US (2) US20030060477A1 (de)
EP (1) EP1272219B1 (de)
JP (1) JP2003528928A (de)
KR (1) KR20020086749A (de)
CN (1) CN1422161A (de)
AR (1) AR030414A1 (de)
AT (1) ATE347909T1 (de)
AU (2) AU4298501A (de)
BR (1) BR0109753A (de)
CA (1) CA2403160A1 (de)
DE (1) DE60125159T2 (de)
EE (1) EE200200570A (de)
ES (1) ES2276774T3 (de)
HU (1) HUP0300332A3 (de)
IL (1) IL151589A0 (de)
IS (1) IS6554A (de)
MX (1) MXPA02009705A (de)
MY (1) MY136386A (de)
NO (1) NO20024732L (de)
NZ (1) NZ521351A (de)
PL (1) PL357813A1 (de)
RU (1) RU2002123591A (de)
SK (1) SK14102002A3 (de)
WO (1) WO2001074394A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
ITMI20040145A1 (it) * 2004-01-30 2004-04-30 Acraf L-moprololo lpiu' tartrato
WO2005077331A1 (en) * 2004-02-11 2005-08-25 Athpharma Limited Chronotherapeutic compositions and methods of their use
ATE525354T1 (de) * 2004-05-03 2011-10-15 Janssen Pharmaceutica Nv Benzofuranderivate als selektive androgenrezeptormodulatoren (sarms)
CN101022791B (zh) * 2004-06-04 2011-11-16 麦兰实验室公司 含奈必洛尔的组合物
CN101534825A (zh) 2006-08-04 2009-09-16 Aska制药株式会社 含有贝特类药物的制剂及其制备方法
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
KR20100045344A (ko) * 2008-10-23 2010-05-03 한올바이오파마주식회사 방출성이 제어된 베타 아드레날린 차단제와 ＨＭＧ-ＣｏＡ 환원 효소 억제제의 신규 복합 조성물
MX344885B (es) * 2008-11-10 2017-01-10 Psicofarma S A De C V Proceso para la obtencion de una composicion de rosuvastatina calcica y producto obtenido.
CN102462844A (zh) * 2010-11-05 2012-05-23 四川滇虹医药开发有限公司 一种替利洛尔的药物组合物及其制备方法
WO2013157833A1 (ko) * 2012-04-18 2013-10-24 서울대학교산학협력단 베타-차단제를 유효성분으로 포함하는 비만, 비만으로 인한 대사성 질환 및 골감소증 예방, 개선 또는 치료용 조성물
CN103613586B (zh) * 2013-11-01 2016-06-08 北京博爱旺康医药科技有限公司 一种旋光纯s-(-)-阿罗洛尔酸式盐及其制备方法和应用
CN103626750B (zh) * 2013-11-15 2016-02-24 北京博爱旺康医药科技有限公司 一种盐酸阿罗洛尔及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
DE69212646T2 (de) * 1991-03-18 1997-03-13 Sepracor Inc Zubereitung und verfahren enthaltend optisch reines s-metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
CA2251972A1 (en) * 1996-04-17 1997-10-23 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
EP1354604A1 (de) * 1998-12-23 2003-10-22 G.D. Searle LLC. Kombinationen für kardiovaskuläre Indikationen

Also Published As

Publication number Publication date
NZ521351A (en) 2004-08-27
JP2003528928A (ja) 2003-09-30
US20030060477A1 (en) 2003-03-27
EP1272219A1 (de) 2003-01-08
KR20020086749A (ko) 2002-11-18
PL357813A1 (en) 2004-07-26
AU2001242985B2 (en) 2005-02-24
IL151589A0 (en) 2003-04-10
AR030414A1 (es) 2003-08-20
NO20024732D0 (no) 2002-10-02
NO20024732L (no) 2002-10-02
HK1051325A1 (en) 2003-08-01
RU2002123591A (ru) 2004-03-20
CN1422161A (zh) 2003-06-04
ES2276774T3 (es) 2007-07-01
EE200200570A (et) 2004-04-15
IS6554A (is) 2002-09-19
HUP0300332A3 (en) 2005-03-29
DE60125159T2 (de) 2007-10-25
BR0109753A (pt) 2003-02-04
WO2001074394A1 (en) 2001-10-11
WO2001074394A8 (en) 2002-05-23
HUP0300332A2 (hu) 2003-06-28
MY136386A (en) 2008-09-30
SK14102002A3 (sk) 2003-06-03
ATE347909T1 (de) 2007-01-15
AU4298501A (en) 2001-10-15
CA2403160A1 (en) 2001-10-11
MXPA02009705A (es) 2004-02-26
EP1272219B1 (de) 2006-12-13
US20040192784A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
DE60125159D1 (de) Neue kombination von einem beta-blocker und einem cholesterin-senkenden mittel
DE69815449D1 (de) Filtrierendes Kosmetisches Mittel
NO993925L (no) Aphron-holdige brönnborings- og vedlikeholdsfluider
DE69903636D1 (de) Beschichtungszusammensetzung und aufzeichnungsmedium
DE69909409D1 (de) Filtermedium
DE69816681D1 (de) Dielektrisches Filter und dielektrischer Duplexer
DE69809811D1 (de) Dielektrisches Filter und dielektrischer Duplexer
DE69820502D1 (de) Dielektrisches Filter und dielektrischer Duplexer
DE69837451D1 (de) Mikrostrukturierter Filter
DE60028417D1 (de) Optisches aufzeichnungsmaterial und neue azaporphyrinverbindungen
ATE318257T1 (de) Trifluoromethylpyrrolcarboxamide und ihre anwendung als fungizide
DE69720312D1 (de) Mehrfachventil und Filter/Abdichtung dafür
ATE224365T1 (de) Neue amidinoderivate und ihre anwendung als thrombin inhibitoren
DE69829160D1 (de) Fluidfilter
DE59912795D1 (de) Substituierte Benzamide und ihre Verwendung als Immunmodulatoren
DE69511268D1 (de) Verhinderung von aschebrückenbildung in keramischen filtern
DE69920699D1 (de) Aminiumsalz- oder diimoniumsalz-verbindungen und ihre anwendung
DE60003389D1 (de) Monolithische zusammensetzung enthaltend feste partikeln und bindemittel
DE69722654D1 (de) Ätherisches öl und verwendung desselben
DE69821330D1 (de) Dielektrisches Filter und dielektrischer Duplexer
DE69932927D1 (de) Cabapenemderivate, ihre anwendung und ihre zwischenprodukte
DE69918433D1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
DE69932653D1 (de) Dielektrisches Filter und dielektrischer Duplexer
DE69842084D1 (de) Mittel gegen ulzerative kolitis
DE69715979D1 (de) Chinolinderivate und ihre Anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee